This inventor holds 4 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Smithkline Beecham Corporation, Glaxosmithkline Intellectual Property (No.2) Limited. Active years: 2005-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Durham, NC (US) (2005 - 2008)
- Research Triangle Park, NC (US) (2017)
Company Filing History:
3 out of 2,198 
1 out of 95 
Years Active: 2005-2017
Title: Inventor Brad Richard Henke: Innovating in Cellular Therapies
Introduction
Brad Richard Henke is an accomplished inventor based in Durham, NC, USA, known for his significant contributions to the field of biotechnology and pharmaceutical research. With four patents to his name, Henke has made strides in developing innovative treatments for metabolic diseases through his work on CD38 inhibitors and hPPARs activators.
Latest Patents
Henke's most recent patents showcase his expertise in therapeutic compounds. His patent on CD38 inhibitors outlines compounds of Formula I and methods for treating metabolic diseases by modulating cellular NAD+ levels via the inhibition of the CD38 enzyme. This innovative approach presents a potential breakthrough in the management of metabolic disorders. Additionally, his patent concerning hPPARs activators includes compounds of formula (1) and their pharmaceutical variants. This invention focuses on treating diseases associated with human PPAR alpha, gamma, or delta by administering a therapeutically effective amount of the compound. Both patents reflect Henke's commitment to pioneering advanced medical therapies.
Career Highlights
Throughout his career, Brad Henke has been affiliated with notable organizations that have shaped his research capabilities. He has worked with SmithKline Beecham Corporation and GlaxoSmithKline Intellectual Property, where he contributed to the development of cutting-edge medical solutions. His experience in these leading corporations has provided him with a robust foundation for innovative thinking and problem-solving in the medical field.
Collaborations
Henke's professional journey includes collaborations with distinguished colleagues such as Rodolfo Cadilla and Millard Hurst Lambert, III. These partnerships have enhanced the scope of his work, allowing for a synergistic approach to research and innovation. The collaborative efforts have further underscored the importance of teamwork in achieving significant advancements in the biotechnology sector.
Conclusion
Brad Richard Henke exemplifies the innovative spirit essential in the realm of biotechnology. His patents not only highlight his achievements as an inventor but also reflect the potential for future breakthroughs in medical treatments. Through his work, Henke continues to impact the field, paving the way for advancements that could transform healthcare outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile